SCHEMBL6624392

SCHEMBL6624392

CCN(C(C)C)C(C)C.Fc1ccc(Nc2ncnc3cc(OCc4ccccc4)cc(OC4CCOCC4)c23)cc1Cl

nearest known ligand 0.68

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.68
ERBB2 P04626 2/20 0.49
SRC P12931 1/20 0.45
KDR P35968 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4032974 0.92 EGFR (0.76) EGFRERBB2SRCKDR
SCHEMBL4033013 0.88 EGFR (0.77) EGFRERBB2
SCHEMBL4033583 0.85 EGFR (0.64) EGFRERBB2
SCHEMBL15643134 0.84 EGFR (0.84) EGFRERBB2SRCKDR
SCHEMBL4032825 0.83 EGFR (0.78) EGFRERBB2SRC
SCHEMBL4036145 0.83 EGFR (0.65) EGFRERBB2
SCHEMBL4034731 0.81 EGFR (0.86) EGFRERBB2SRCKDR
SCHEMBL4038435 0.81 EGFR (1.00) EGFRSRCKDR
SCHEMBL4036152 0.81 EGFR (1.00) EGFRSRCKDR
SCHEMBL4033880 0.81 EGFR (0.85) EGFRERBB2SRCKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444211-A2 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2004-08-11 EP disclosed
WO-2003040109-A2 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2003-05-15 WO disclosed